Turmeric extract tested to stop stomach cancer before it starts
NCT ID NCT02782949
Summary
This study is testing whether a curcumin supplement (Meriva®), derived from turmeric, can help prevent stomach cancer in people who have a pre-cancerous stomach condition called chronic atrophic gastritis. Fifty participants will take either the curcumin supplement or a placebo pill twice daily for six months. Researchers will measure changes in stomach inflammation and tissue damage to see if the supplement is effective.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Regional de Occidente
Santa Rosa de Copán, 41101, Honduras
-
University of Puerto Rico
San Juan, 00936, Puerto Rico
Conditions
Explore the condition pages connected to this study.